LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article ; Online: Clozapine and neutrophil response in patients of African descent: A six-month, multinational, prospective, open-label clinical trial.

    Kelly, Deanna L / Glassman, Matthew / Wonodi, Ikwunga / Vyas, Gopal / Richardson, Charles M / Nwulia, Evaristus / Wehring, Heidi J / Oduguwa, Taiwo / Mackowick, Marie / Hipolito, Maria Mananita S / Peters, Olawunmi / Rai, Narayan / Park, Jaeboon / Adebayo, Adeola O / Gorelick, David A / Weiner, Elaine / Liu, Fang / Kearns, Ann Marie / Adams, Heather A /
    Love, Raymond C / Chen, Shuo / Olaniyan, Ayodeji / Ambulos, Nicholas / McKoy, Darius / Nallani, Madhulika C / Lanzkron, Sophie / Mengistab, Mulu / Barr, Brian / Davis, Erica / Lawal, Rahman / Buchanan, Robert W / Adebayo, Richard

    Schizophrenia research

    2023  

    Abstract: Introduction: Clozapine is the most effective antipsychotic for treatment-resistant schizophrenia, but it is markedly underutilized, particularly in the US Black population, partly because of concern over clozapine-associated low absolute neutrophil ... ...

    Abstract Introduction: Clozapine is the most effective antipsychotic for treatment-resistant schizophrenia, but it is markedly underutilized, particularly in the US Black population, partly because of concern over clozapine-associated low absolute neutrophil count (ANC). People of African descent have a lower normative ANC range than the White population, which is associated with a specific "ACKR1-null" ("Duffy null") CC genotype (SNP rs2814778) on the ACKR1 gene, termed benign ethnic neutropenia (BEN). The range of ANC variability and safety of clozapine have not been established in people with BEN or examined prospectively in people of African descent.
    Methods: We completed a multisite, 6-month, prospective, open-label clinical trial of clozapine treatment in people of African descent with schizophrenia spectrum disorders for whom clozapine was clinically indicated, with or without the ACKR1-null genotype. We examined clozapine safety and weekly ANC during clozapine treatment and evaluated ANC variability by ACKR1-null genotype, sex, study site, and clozapine dosing using repeated measures analysis of covariance. Genotype was assayed using TaqMan® technology.
    Results: We enrolled 274 participants, of whom 227 (82.8 %) completed 6 months of clozapine treatment. There was one case of severe neutropenia (<500 cells/mm
    Conclusion: To our knowledge, this is the largest prospective clozapine trial in people of African descent. Severe neutropenia was rare, despite the high prevalence (80 %) of the ACKR1-null genotype. Our findings suggest that clozapine can be used safely in Black patients including those with BEN.
    Language English
    Publishing date 2023-08-24
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 639422-x
    ISSN 1573-2509 ; 0920-9964
    ISSN (online) 1573-2509
    ISSN 0920-9964
    DOI 10.1016/j.schres.2023.08.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Chronic exposure to low-dose arsenic modulates lipogenic gene expression in mice.

    Adebayo, Adeola O / Zandbergen, Fokko / Kozul-Horvath, Courtney D / Gruppuso, Philip A / Hamilton, Joshua W

    Journal of biochemical and molecular toxicology

    2014  Volume 29, Issue 1, Page(s) 1–9

    Abstract: Arsenic, a ubiquitous environmental toxicant, can affect lipid metabolism through mechanisms that are not well understood. We studied the effect of arsenic on serum lipids, lipid-regulating genes, and transcriptional regulator sterol regulatory element ... ...

    Abstract Arsenic, a ubiquitous environmental toxicant, can affect lipid metabolism through mechanisms that are not well understood. We studied the effect of arsenic on serum lipids, lipid-regulating genes, and transcriptional regulator sterol regulatory element binding protein 1c (SREBP-1c). C57BL/6 mice were administered 0 or 100 ppb sodium arsenite in drinking water for 5 weeks. Arsenic exposure was associated with decreased liver weight but no change in body weight. Serum triglycerides level fell in arsenic-exposed animals, but not in fed animals, after short-term fasting. Hepatic expression of SREBP-1c was reduced in arsenic-exposed fed animals, with a 16-fold change in reduction. Similar effects were seen for SREBP-1c in white adipose tissue. However, fasting resulted in dissociation of the expression of SREBP-1c and its targets, and SREBP-1c protein content could not be shown to correlate with its mRNA expression. We conclude that arsenic modulates hepatic expression of genes involved in lipid regulation through mechanisms that are independent of SREBP-1c expression.
    MeSH term(s) Adipose Tissue, White/metabolism ; Animals ; Arsenic/pharmacology ; Arsenites/pharmacology ; Enzyme Inhibitors/pharmacology ; Gene Expression Regulation/drug effects ; Lipogenesis/drug effects ; Liver/metabolism ; Male ; Mice ; Sodium Compounds/pharmacology ; Sterol Regulatory Element Binding Protein 1/biosynthesis ; Triglycerides/biosynthesis
    Chemical Substances Arsenites ; Enzyme Inhibitors ; Sodium Compounds ; Srebf1 protein, mouse ; Sterol Regulatory Element Binding Protein 1 ; Triglycerides ; sodium arsenite (48OVY2OC72) ; Arsenic (N712M78A8G)
    Language English
    Publishing date 2014-08-23
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 1410020-4
    ISSN 1099-0461 ; 1095-6670
    ISSN (online) 1099-0461
    ISSN 1095-6670
    DOI 10.1002/jbt.21600
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Persistent effect of mTOR inhibition on preneoplastic foci progression and gene expression in a rat model of hepatocellular carcinoma.

    Francois-Vaughan, Heather / Adebayo, Adeola O / Brilliant, Kate E / Parry, Nicola M A / Gruppuso, Philip A / Sanders, Jennifer A

    Carcinogenesis

    2016  Volume 37, Issue 4, Page(s) 408–419

    Abstract: Hepatocellular carcinoma (HCC) is a heterogeneous disease in which tumor subtypes can be identified based on the presence of adult liver progenitor cells. Having previously identified the mTOR pathway as critical to progenitor cell proliferation in a ... ...

    Abstract Hepatocellular carcinoma (HCC) is a heterogeneous disease in which tumor subtypes can be identified based on the presence of adult liver progenitor cells. Having previously identified the mTOR pathway as critical to progenitor cell proliferation in a model of liver injury, we investigated the temporal activation of mTOR signaling in a rat model of hepatic carcinogenesis. The model employed chemical carcinogens and partial hepatectomy to induce progenitor marker-positive HCC. Immunohistochemical staining for phosphorylated ribosomal protein S6 indicated robust mTOR complex 1 (mTORC1) activity in early preneoplastic lesions that peaked during the first week and waned over the subsequent 10 days. Continuous administration of rapamycin by subcutaneous pellet for 70 days markedly reduced the development of focal lesions, but resulted in activation of the PI3K signaling pathway. To test the hypothesis that early mTORC1 activation was critical to the development and progression of preneoplastic foci, we limited rapamycin administration to the 3-week period at the start of the protocol. Focal lesion burden was reduced to a degree indistinguishable from that seen with continuous administration. Short-term rapamycin did not result in the activation of PI3K or mTORC2 pathways. Microarray analysis revealed a persistent effect of short-term mTORC1 inhibition on gene expression that resulted in a genetic signature reminiscent of normal liver. We conclude that mTORC1 activation during the early stages of hepatic carcinogenesis may be critical due to the development of preneoplastic focal lesions in progenitor marker-positive HCC. mTORC1 inhibition may represent an effective chemopreventive strategy for this form of liver cancer.
    MeSH term(s) Animals ; Carcinoma, Hepatocellular/surgery ; Disease Progression ; Gene Expression ; Liver Neoplasms/surgery ; Male ; Rats ; Rats, Inbred F344 ; TOR Serine-Threonine Kinases/antagonists & inhibitors
    Chemical Substances TOR Serine-Threonine Kinases (EC 2.7.1.1) ; mTOR protein, rat (EC 2.7.1.1)
    Language English
    Publishing date 2016-04
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 603134-1
    ISSN 1460-2180 ; 0143-3334
    ISSN (online) 1460-2180
    ISSN 0143-3334
    DOI 10.1093/carcin/bgw016
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top